Kolexia
Chiron Raphael Pédiatrie
Chiron Raphael
Pédiatrie
Hôpital Arnaud de Villeneuve
Limoges, France
188 Activités
20 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Maladies pulmonaires Infections à Pseudomonas Asthme Inflammation Infections à mycobactéries non tuberculeuses Rhinite Infections bactériennes à Gram négatif

Collaborateurs

Voir plus
Marchandin Helene
Marchandin Helene
Hôpital Carémeau, Nîmes, France
Caimmi Davide
Caimmi Davide
Hôpital Arnaud de Villeneuve, Limoges, France
Burgel Pierre-Regis
Burgel Pierre-Regis
Hôpital Cochin, Paris, France
Durieu Isabelle
Durieu Isabelle
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Zambon
12 collaboration(s)
Dernière en 2023
Vertex
10 collaboration(s)
Dernière en 2023
Schlesinger Group France
3 collaboration(s)
Dernière en 2023
Inter-View Partners France
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Prevalence and variability of siderophore production in the genus.
Microbiology spectrum   05 février 2024
Gathering real-world compassionate data to expand eligibility to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with N1303K or other rare variants: a viewpoint.
The European respiratory journal   19 janvier 2024
Highly diverse dynamics of Pseudomonas aeruginosa colonization from initial detection in cystic fibrosis patients: A 7-year longitudinal genetic diversity study.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases   11 octobre 2023
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA
The journal of nutrition, health & aging   01 août 2023
DCP: Primary Ciliary Dyskinesias: Identification of Specific Severity Criteria and Phenotype-genotype Correlation Study
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   18 juillet 2023
KAF-BIOTA: Monitoring of the Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor: Study of the Pulmonary and Gut Microbiota and Inflammation
Essai Clinique (CHU Bordeaux)   07 juillet 2023
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   06 juillet 2023
P075 Discrepancy between in vitro CFTR functional analysis and clinical response to elexacaftor/tezacaftor/ivacaftor (ETI) in a homozygous S364P (c.1090T>C) patient with cystic fibrosis
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
WS10.01 The French Compassionate Programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
P266 Genomic and phenotypic comparisons of Pseudomonas aeruginosa ST27 strains isolated from respiratory tract and domestic environment of a cystic fibrosis patient
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023